"AI Scientists"—New Collaborators for Rare Disease Research?
In the quest to understand and treat the over 6,000 rare diseases, researchers encounter a number of limitations – in …
Biopharma Insights
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding …
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years …
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is …
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying …
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models …
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
Pharmaceutical companies are dealing with an unprecedented volume of safety data with artificial intelligence moving from theoretical applications to practical …
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical …
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration …
The Future of Advanced Therapeutics: Opportunities and Challenges
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These …
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
In a rapidly evolving clinical research landscape, there is a greater need now more than ever for pharma and biotech …
21 Life Science Marketplaces to Try in 2024
(Last Update: December 2024, by adding Lab Spend, Labviva and more) A life sciences marketplace is an online platform that operates with a …